Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma
This study presents a case of a 17-year-old female patient who had previously undergone surgical resection of melanoma in the right periscapular area. She was administered adjuvant treatment with the PD-1 inhibitor nivolumab as monotherapy. The mechanism of action of this drug is based on increased...
| Main Authors: | Aleksandra Grzegorczyk, Zuzanna Marczyńska, Rafał Matkowski, Marcin Ziętek, Wojciech Pietras, Elżbieta Latos-Grażyńska, Krzysztof Kałwak, Iwona Dachowska-Kałwak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2023-08-01
|
| Series: | Central European Journal of Immunology |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Severe-complications-of-nivolumab-r-nmonotherapy-in-an-adolescent-r-nwith-malignant-melanoma,10,51327,1,1.html |
Similar Items
-
Nivolumab-Induced Thyroid Dysfunction
by: Lohit Kumbar, et al.
Published: (2021-01-01) -
Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma
by: Seiichi Yano, et al.
Published: (2018-06-01) -
Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
by: Ravi Potluri, et al.
Published: (2019-07-01) -
Nivolumab-induced autoimmune diabetes mellitus and hypothyroidism in a patient with rectal neuroendocrine tumor
by: Waqas Haque, et al.
Published: (2020-07-01) -
Bullous pemphigoid associated with the use of nivolumab in a patient with metastatic melanoma: a case report.
by: Diego Lopes Paim Miranda, et al.
Published: (2020-01-01)